Palomino Laboratories (PALX) Return on Equity (2023 - 2025)

Palomino Laboratories' Return on Equity history runs 3 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Equity fell 17.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (down 17.0% YoY), while the FY2024 annual figure was 0.08%, up 4.0% from the prior year.
• Return on Equity came in at 0.0% for Q4 2025 at Palomino Laboratories, up from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.73% in Q2 2024 to a low of 0.01% in Q3 2025.
• A 3-year average of 0.13% and a median of 0.01% in 2023 frame the typical range for Return on Equity.
• Across the five-year window, Return on Equity gained 22 bps in 2024 and tumbled 72 bps in 2025, its largest moves.
• Palomino Laboratories' Return on Equity stood at 0.02% in 2023, then surged by 966 bps to 0.17% in 2024, then sank by 101 bps to 0.0% in 2025.
• According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.01%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison